ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase

Wang, Chao J.; Li, Deren; Danielson, Jacob A.; Zhang, Evan H.; Dong, Zizheng; Miller, Kathy D.; Li, Lang; Zhang, Jian-Ting*; Liu, Jing-Yuan*
Cancer Letters2021-7-1DOI: 10.1016/j.canlet.2021.03.026
6阅读
引用收藏
分享

摘要

Human fatty acid synthase (FASN) is the sole cytosolic enzyme responsible for de novo lipid synthesis. FASN is essential for cancer cell survival and contributes to drug and radiation resistance by up-regulating DNA damage repair but not required for most non-lipogenic tissues. Thus, FASN is an attractive target for drug discovery. However, despite decades of effort in targeting FASN, no FASN inhibitors have been approved due to poor pharmacokinetics or toxicities. Here, we show that the FDA-approved proton pump inhibitors (PPIs) effectively inhibit FASN and suppress breast cancer cell survival. PPI inhibition of FASN leads to suppression of nonhomologous end joining repair of DNA damages by reducing FASN-mediated PARP1 expression, resulting in apoptosis from oxidative DNA damages and sensitization of cellular resistance to doxorubicin and ionizing radiation. Mining electronic medical records of 6754 breast cancer patients showed that PPI usage significantly increased overall survival and reduced disease recurrence of these patients. Hence, PPIs may be repurposed as anticancer drugs for breast cancer treatments by targeting FASN to overcome drug and radiation resistance.

学科与关键词

关键词
Fatty acid synthaseProton pump inhibitorEnantiomerDNA damage RepairPARP1
相关
加载中…
  • High-dose radiation-resistant lung cancer cells stored many functional lipid drops through JAK2/p-STAT3/FASN pathway
    Yang, Ting; Qiao, Simiao; Zhu, Xiaoxia*Journal of Cancer Research and Clinical Oncology, 2023, 149(15): 14169-14183.
  • FASN contributes to ADM resistance of diffuse large B-cell lymphoma by inhibiting ferroptosis via nf-κB/STAT3/GPX4 axis
    Zhong, Xing; Zhang, Weiwei; Zhang, Weiming; Yu, Nasha; Li, Wuping; Song, XiangxiangCANCER BIOLOGY & THERAPY, 2024, 25(1): 2403197.
  • PI3K/AKT/mTOR通路调控乳腺癌细胞FASN过表达的分子机制
    陈衍; 韩晟; 刘文超现代肿瘤医学, 2013, (01): 1-4.
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Letters
发表日期
2021-07-01
卷期
第 509 卷
页码
1-12
DOI
10.1016/j.canlet.2021.03.026
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
DoDUnited States Department of Defense [W81XWH-16-1-0030]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 GM127656]; Breast Cancer Research Foundation

作者

  • W

    Wang, Chao J. (第一作者)

  • L

    Li, Deren

查看全部 9 位作者收起作者
  • D

    Danielson, Jacob A.

  • Z

    Zhang, Evan H.

  • D

    Dong, Zizheng

  • M

    Miller, Kathy D.

  • L

    Li, Lang

  • Z

    Zhang, Jian-Ting (通讯)

  • L

    Liu, Jing-Yuan (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417